AVIR SG&A Expense Growth
Atea Pharmaceuticals Inc · SG&A Expense Growth
AVIR SG&A Expense Growth
Latest reported-32.73%period ending
AVIR FY SG&A Growth (YoY) (0.00% → -32.73%)
Latest values, visible window
High-resolution chart · PNG
AVIR sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -32.7253% | |
| -2.1435% | |
| 2.4736% | |
| 6.3973% | |
| 111.5758% | |
| 387.607% | |
| 58.3869% | |
| 0% |